Standout Papers

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoin... 2019 2026 2021 2023 392
  1. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade (2019)
    Imran G. House, Peter Savas et al. Clinical Cancer Research

Immediate Impact

4 by Nobel laureates 15 from Science/Nature 63 standout
Sub-graph 1 of 20

Citing Papers

Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
2025 Standout
Cross-priming in cancer immunology and immunotherapy
2025 Standout

Works of Lauren Giuffrida being referenced

Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
2020
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
2019 Standout

Author Peers

Author Last Decade Papers Cites
Lauren Giuffrida 679 851 52 368 14 1.3k
Kevin Sek 724 889 10 399 10 1.3k
Ryan Cross 427 793 15 398 30 1.1k
Melissa A. Henderson 794 1040 5 432 17 1.4k
Junyun Lai 676 775 7 327 16 1.1k
Sherly Mardiana 797 1128 5 430 13 1.5k
Jenny J. Hong 438 784 110 606 23 1.4k
Swetha Anandhan 842 880 7 583 13 1.6k
Esteban Carrizosa 1011 450 20 503 13 1.5k
Qijin Xu 167 253 22 462 23 1.0k
Horacio Soto 685 754 17 651 28 1.6k

All Works

Loading papers...

Rankless by CCL
2026